Drug Discovery and Development
Course, Master's level, 3FK229
Expand the information below to show details on how to apply and entry requirements.
Autumn 2025 Autumn 2025, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 1 September 2025–1 October 2025
- Language of instruction
- English
- Entry requirements
-
150 credits of which 90 credits in biomedicine, pharmaceutical science, natural science and/or technology. Prior studies should include 10 credits in chemistry and 7.5 credits in pharmacology. Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
- If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application deadline
- 15 April 2025
- Application code
- UU-35004
Admitted or on the waiting list?
- Registration period
- 25 July 2025–24 August 2025
- Information on registration from the department
Autumn 2025 Autumn 2025, Uppsala, 100%, On-campus, English For exchange students
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 1 September 2025–1 October 2025
- Language of instruction
- English
- Entry requirements
-
150 credits of which 90 credits in biomedicine, pharmaceutical science, natural science and/or technology. Prior studies should include 10 credits in chemistry and 7.5 credits in pharmacology. Proficiency in English equivalent to the Swedish upper secondary course English 6.
Admitted or on the waiting list?
- Registration period
- 25 July 2025–24 August 2025
- Information on registration from the department
Expand the information below to show details on how to apply and entry requirements.
Spring 2026 Spring 2026, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 19 January 2026–19 February 2026
- Language of instruction
- English
- Entry requirements
-
150 credits of which 90 credits in biomedicine, pharmaceutical science, natural science and/or technology. Prior studies should include 10 credits in chemistry and 7.5 credits in pharmacology. Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
- If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application deadline
- 15 October 2025
- Application code
- UU-85004
Admitted or on the waiting list?
- Registration period
- 12 January 2026–19 January 2026
- Information on registration from the department
Spring 2026 Spring 2026, Uppsala, 100%, On-campus, English For exchange students
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 19 January 2026–19 February 2026
- Language of instruction
- English
- Entry requirements
-
150 credits of which 90 credits in biomedicine, pharmaceutical science, natural science and/or technology. Prior studies should include 10 credits in chemistry and 7.5 credits in pharmacology. Proficiency in English equivalent to the Swedish upper secondary course English 6.
Admitted or on the waiting list?
- Registration period
- 12 January 2026–19 January 2026
- Information on registration from the department
About the course
The course deals with different phases in drug development; identification and validation of target molecule (the target), identification and optimisation of active substance, ADME-Tox profiling, in-vivo and in-vitro pharmacology, formulation, discovery and biomarkers and disease models, clinical trials, registration and commercialisation.